News
The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...
12d
Zacks.com on MSNCVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...
Lastly, Health Care Benefit adjusted operating income is expected to reach around $1.91 billion, an increase of approximately $400 million. The gain largely reflects the prior-year reserve development ...
8d
Zacks.com on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
UnitedHealth Group is under criminal and civil investigation by the DOJ over alleged Medicare fraud, raising serious ...
Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...
A federal judge on Wednesday said he will try to issue a ruling soon on whether a new state law banning pharmacies operated ...
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2. Read more ...
13hon MSN
California's budget includes a provision for pharmacy benefit managers to be licensed in the state, an effort Sen. Scott ...
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
Lifted by the continued buying in artificial intelligence suppliers, the S&P 500 (SPY) closed at a record high. Alphabet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results